In almost all the cases, the direct targeting of p140Cap has been validated in cancer cell lines and the resulting downregulation of p140Cap expression promotes tumor features such as proliferation [56–68], migration [56, 58, 60, 61, 63, 67, 68], invasion [60, 64] and angiogenesis [69]. This evidence concerns the gene SRCIN1 and cancer.